IBDEI2UZ ; ; 04-FEB-2020
;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 04, 2020
Q:'DIFQR(358.3) F I=1:2 S X=$T(Q+I) Q:X="" S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E S @X=Y
Q Q
;;^UTILITY(U,$J,358.3,45602,2)
;;=^5019209
;;^UTILITY(U,$J,358.3,45603,0)
;;=R09.1^^172^2273^39
;;^UTILITY(U,$J,358.3,45603,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,45603,1,3,0)
;;=3^Pleurisy
;;^UTILITY(U,$J,358.3,45603,1,4,0)
;;=4^R09.1
;;^UTILITY(U,$J,358.3,45603,2)
;;=^95428
;;^UTILITY(U,$J,358.3,45604,0)
;;=Z95.1^^172^2273^43
;;^UTILITY(U,$J,358.3,45604,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,45604,1,3,0)
;;=3^Presence of aortocoronary bypass graft
;;^UTILITY(U,$J,358.3,45604,1,4,0)
;;=4^Z95.1
;;^UTILITY(U,$J,358.3,45604,2)
;;=^5063669
;;^UTILITY(U,$J,358.3,45605,0)
;;=Z95.3^^172^2273^44
;;^UTILITY(U,$J,358.3,45605,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,45605,1,3,0)
;;=3^Presence of xenogenic heart valve
;;^UTILITY(U,$J,358.3,45605,1,4,0)
;;=4^Z95.3
;;^UTILITY(U,$J,358.3,45605,2)
;;=^5063671
;;^UTILITY(U,$J,358.3,45606,0)
;;=R21.^^172^2273^46
;;^UTILITY(U,$J,358.3,45606,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,45606,1,3,0)
;;=3^Rash & oth nonspecific skin eruption
;;^UTILITY(U,$J,358.3,45606,1,4,0)
;;=4^R21.
;;^UTILITY(U,$J,358.3,45606,2)
;;=^5019283
;;^UTILITY(U,$J,358.3,45607,0)
;;=Z12.9^^172^2273^47
;;^UTILITY(U,$J,358.3,45607,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,45607,1,3,0)
;;=3^Screening malig neop site unspec
;;^UTILITY(U,$J,358.3,45607,1,4,0)
;;=4^Z12.9
;;^UTILITY(U,$J,358.3,45607,2)
;;=^5062698
;;^UTILITY(U,$J,358.3,45608,0)
;;=R06.02^^172^2273^48
;;^UTILITY(U,$J,358.3,45608,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,45608,1,3,0)
;;=3^Shortness of breath
;;^UTILITY(U,$J,358.3,45608,1,4,0)
;;=4^R06.02
;;^UTILITY(U,$J,358.3,45608,2)
;;=^5019181
;;^UTILITY(U,$J,358.3,45609,0)
;;=R00.0^^172^2273^54
;;^UTILITY(U,$J,358.3,45609,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,45609,1,3,0)
;;=3^Tachycardia, unspecified
;;^UTILITY(U,$J,358.3,45609,1,4,0)
;;=4^R00.0
;;^UTILITY(U,$J,358.3,45609,2)
;;=^5019163
;;^UTILITY(U,$J,358.3,45610,0)
;;=R32.^^172^2273^56
;;^UTILITY(U,$J,358.3,45610,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,45610,1,3,0)
;;=3^Urinary incontinence, unspec
;;^UTILITY(U,$J,358.3,45610,1,4,0)
;;=4^R32.
;;^UTILITY(U,$J,358.3,45610,2)
;;=^5019329
;;^UTILITY(U,$J,358.3,45611,0)
;;=R33.9^^172^2273^57
;;^UTILITY(U,$J,358.3,45611,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,45611,1,3,0)
;;=3^Urine retention, unspec
;;^UTILITY(U,$J,358.3,45611,1,4,0)
;;=4^R33.9
;;^UTILITY(U,$J,358.3,45611,2)
;;=^5019332
;;^UTILITY(U,$J,358.3,45612,0)
;;=R53.1^^172^2273^58
;;^UTILITY(U,$J,358.3,45612,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,45612,1,3,0)
;;=3^Weakness
;;^UTILITY(U,$J,358.3,45612,1,4,0)
;;=4^R53.1
;;^UTILITY(U,$J,358.3,45612,2)
;;=^5019516
;;^UTILITY(U,$J,358.3,45613,0)
;;=R63.4^^172^2273^59
;;^UTILITY(U,$J,358.3,45613,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,45613,1,3,0)
;;=3^Weight loss, abnormal
;;^UTILITY(U,$J,358.3,45613,1,4,0)
;;=4^R63.4
;;^UTILITY(U,$J,358.3,45613,2)
;;=^5019542
;;^UTILITY(U,$J,358.3,45614,0)
;;=B18.2^^172^2273^28
;;^UTILITY(U,$J,358.3,45614,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,45614,1,3,0)
;;=3^Hepatitis C Carrier,Viral
;;^UTILITY(U,$J,358.3,45614,1,4,0)
;;=4^B18.2
;;^UTILITY(U,$J,358.3,45614,2)
;;=^5000548
;;^UTILITY(U,$J,358.3,45615,0)
;;=Z98.890^^172^2273^42
;;^UTILITY(U,$J,358.3,45615,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,45615,1,3,0)
;;=3^Postprocedural States,Other Specified
--- Routine Detail --- with STRUCTURED ROUTINE LISTING ---[H[J[2J[HIBDEI2UZ 3825 printed Apr 09, 2024@21:15:33 Page 2
IBDEI2UZ ; ; 04-FEB-2020
+1 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 04, 2020
+2 if 'DIFQR(358.3)
QUIT
FOR I=1:2
SET X=$TEXT(Q+I)
if X=""
QUIT
SET Y=$EXTRACT($TEXT(Q+I+1),4,999)
SET X=$EXTRACT(X,4,999)
if $ASCII(Y)=126
SET I=I+1
SET Y=$EXTRACT(Y,2,999)_$EXTRACT($TEXT(Q+I+1),5,999)
if $ASCII(Y)=61
SET Y=$EXTRACT(Y,2,999)
XECUTE NO
IF '$TEST
SET @X=Y
Q QUIT
+1 ;;^UTILITY(U,$J,358.3,45602,2)
+2 ;;=^5019209
+3 ;;^UTILITY(U,$J,358.3,45603,0)
+4 ;;=R09.1^^172^2273^39
+5 ;;^UTILITY(U,$J,358.3,45603,1,0)
+6 ;;=^358.31IA^4^2
+7 ;;^UTILITY(U,$J,358.3,45603,1,3,0)
+8 ;;=3^Pleurisy
+9 ;;^UTILITY(U,$J,358.3,45603,1,4,0)
+10 ;;=4^R09.1
+11 ;;^UTILITY(U,$J,358.3,45603,2)
+12 ;;=^95428
+13 ;;^UTILITY(U,$J,358.3,45604,0)
+14 ;;=Z95.1^^172^2273^43
+15 ;;^UTILITY(U,$J,358.3,45604,1,0)
+16 ;;=^358.31IA^4^2
+17 ;;^UTILITY(U,$J,358.3,45604,1,3,0)
+18 ;;=3^Presence of aortocoronary bypass graft
+19 ;;^UTILITY(U,$J,358.3,45604,1,4,0)
+20 ;;=4^Z95.1
+21 ;;^UTILITY(U,$J,358.3,45604,2)
+22 ;;=^5063669
+23 ;;^UTILITY(U,$J,358.3,45605,0)
+24 ;;=Z95.3^^172^2273^44
+25 ;;^UTILITY(U,$J,358.3,45605,1,0)
+26 ;;=^358.31IA^4^2
+27 ;;^UTILITY(U,$J,358.3,45605,1,3,0)
+28 ;;=3^Presence of xenogenic heart valve
+29 ;;^UTILITY(U,$J,358.3,45605,1,4,0)
+30 ;;=4^Z95.3
+31 ;;^UTILITY(U,$J,358.3,45605,2)
+32 ;;=^5063671
+33 ;;^UTILITY(U,$J,358.3,45606,0)
+34 ;;=R21.^^172^2273^46
+35 ;;^UTILITY(U,$J,358.3,45606,1,0)
+36 ;;=^358.31IA^4^2
+37 ;;^UTILITY(U,$J,358.3,45606,1,3,0)
+38 ;;=3^Rash & oth nonspecific skin eruption
+39 ;;^UTILITY(U,$J,358.3,45606,1,4,0)
+40 ;;=4^R21.
+41 ;;^UTILITY(U,$J,358.3,45606,2)
+42 ;;=^5019283
+43 ;;^UTILITY(U,$J,358.3,45607,0)
+44 ;;=Z12.9^^172^2273^47
+45 ;;^UTILITY(U,$J,358.3,45607,1,0)
+46 ;;=^358.31IA^4^2
+47 ;;^UTILITY(U,$J,358.3,45607,1,3,0)
+48 ;;=3^Screening malig neop site unspec
+49 ;;^UTILITY(U,$J,358.3,45607,1,4,0)
+50 ;;=4^Z12.9
+51 ;;^UTILITY(U,$J,358.3,45607,2)
+52 ;;=^5062698
+53 ;;^UTILITY(U,$J,358.3,45608,0)
+54 ;;=R06.02^^172^2273^48
+55 ;;^UTILITY(U,$J,358.3,45608,1,0)
+56 ;;=^358.31IA^4^2
+57 ;;^UTILITY(U,$J,358.3,45608,1,3,0)
+58 ;;=3^Shortness of breath
+59 ;;^UTILITY(U,$J,358.3,45608,1,4,0)
+60 ;;=4^R06.02
+61 ;;^UTILITY(U,$J,358.3,45608,2)
+62 ;;=^5019181
+63 ;;^UTILITY(U,$J,358.3,45609,0)
+64 ;;=R00.0^^172^2273^54
+65 ;;^UTILITY(U,$J,358.3,45609,1,0)
+66 ;;=^358.31IA^4^2
+67 ;;^UTILITY(U,$J,358.3,45609,1,3,0)
+68 ;;=3^Tachycardia, unspecified
+69 ;;^UTILITY(U,$J,358.3,45609,1,4,0)
+70 ;;=4^R00.0
+71 ;;^UTILITY(U,$J,358.3,45609,2)
+72 ;;=^5019163
+73 ;;^UTILITY(U,$J,358.3,45610,0)
+74 ;;=R32.^^172^2273^56
+75 ;;^UTILITY(U,$J,358.3,45610,1,0)
+76 ;;=^358.31IA^4^2
+77 ;;^UTILITY(U,$J,358.3,45610,1,3,0)
+78 ;;=3^Urinary incontinence, unspec
+79 ;;^UTILITY(U,$J,358.3,45610,1,4,0)
+80 ;;=4^R32.
+81 ;;^UTILITY(U,$J,358.3,45610,2)
+82 ;;=^5019329
+83 ;;^UTILITY(U,$J,358.3,45611,0)
+84 ;;=R33.9^^172^2273^57
+85 ;;^UTILITY(U,$J,358.3,45611,1,0)
+86 ;;=^358.31IA^4^2
+87 ;;^UTILITY(U,$J,358.3,45611,1,3,0)
+88 ;;=3^Urine retention, unspec
+89 ;;^UTILITY(U,$J,358.3,45611,1,4,0)
+90 ;;=4^R33.9
+91 ;;^UTILITY(U,$J,358.3,45611,2)
+92 ;;=^5019332
+93 ;;^UTILITY(U,$J,358.3,45612,0)
+94 ;;=R53.1^^172^2273^58
+95 ;;^UTILITY(U,$J,358.3,45612,1,0)
+96 ;;=^358.31IA^4^2
+97 ;;^UTILITY(U,$J,358.3,45612,1,3,0)
+98 ;;=3^Weakness
+99 ;;^UTILITY(U,$J,358.3,45612,1,4,0)
+100 ;;=4^R53.1
+101 ;;^UTILITY(U,$J,358.3,45612,2)
+102 ;;=^5019516
+103 ;;^UTILITY(U,$J,358.3,45613,0)
+104 ;;=R63.4^^172^2273^59
+105 ;;^UTILITY(U,$J,358.3,45613,1,0)
+106 ;;=^358.31IA^4^2
+107 ;;^UTILITY(U,$J,358.3,45613,1,3,0)
+108 ;;=3^Weight loss, abnormal
+109 ;;^UTILITY(U,$J,358.3,45613,1,4,0)
+110 ;;=4^R63.4
+111 ;;^UTILITY(U,$J,358.3,45613,2)
+112 ;;=^5019542
+113 ;;^UTILITY(U,$J,358.3,45614,0)
+114 ;;=B18.2^^172^2273^28
+115 ;;^UTILITY(U,$J,358.3,45614,1,0)
+116 ;;=^358.31IA^4^2
+117 ;;^UTILITY(U,$J,358.3,45614,1,3,0)
+118 ;;=3^Hepatitis C Carrier,Viral
+119 ;;^UTILITY(U,$J,358.3,45614,1,4,0)
+120 ;;=4^B18.2
+121 ;;^UTILITY(U,$J,358.3,45614,2)
+122 ;;=^5000548
+123 ;;^UTILITY(U,$J,358.3,45615,0)
+124 ;;=Z98.890^^172^2273^42
+125 ;;^UTILITY(U,$J,358.3,45615,1,0)
+126 ;;=^358.31IA^4^2
+127 ;;^UTILITY(U,$J,358.3,45615,1,3,0)
+128 ;;=3^Postprocedural States,Other Specified
